
Sign up to save your podcasts
Or


Interest in Ozempic as a way to lose weight has only been outmatched by demand for the drug, which has been in short supply as celebrities and social media influencers continue to popularize its use. The Type 2 diabetes treatment, which was approved by the Food and Drug Administration in 2017, has become a catch-all term for a class of medications now used to treat obesity, including Wegovy, Zepbound and others. The efficacy of these drugs have some in the medical community pondering if we are on a path to effectively eliminating obesity by treating it as a chronic disease, rather than solely treating the diseases most often related to it.
Kai invites Dr. Fatima Cody Stanford, an obesity medicine physician scientist and associate professor of medicine at Massachusetts General Hospital, to explain how these latest weight loss treatments work, and who can (and can’t) access them. Plus, Ronald Young Jr., host of the podcast Weight For It, joins the show to share his experience and express some concerns about how Ozempic and similar drugs have dominated the conversation about our bodies and our health. And we hear from listeners around the country who weigh in with their questions and stories.
Tell us what you think. We're @noteswithkai on Instagram and X (Twitter). Email us at [email protected]. Send us a voice message by recording yourself on your phone and emailing us, or record one here.
Notes from America airs live on Sundays at 6 p.m. ET. The podcast episodes are lightly edited from our live broadcasts.
Tell us what you think. We're @noteswithkai on Instagram and X (Twitter). Email us at [email protected]. Send us a voice message by recording yourself on your phone and emailing us, or record one here.
Notes from America airs live on Sundays at 6 p.m. ET. The podcast episodes are lightly edited from our live broadcasts.
By WNYC Studios4.3
15401,540 ratings
Interest in Ozempic as a way to lose weight has only been outmatched by demand for the drug, which has been in short supply as celebrities and social media influencers continue to popularize its use. The Type 2 diabetes treatment, which was approved by the Food and Drug Administration in 2017, has become a catch-all term for a class of medications now used to treat obesity, including Wegovy, Zepbound and others. The efficacy of these drugs have some in the medical community pondering if we are on a path to effectively eliminating obesity by treating it as a chronic disease, rather than solely treating the diseases most often related to it.
Kai invites Dr. Fatima Cody Stanford, an obesity medicine physician scientist and associate professor of medicine at Massachusetts General Hospital, to explain how these latest weight loss treatments work, and who can (and can’t) access them. Plus, Ronald Young Jr., host of the podcast Weight For It, joins the show to share his experience and express some concerns about how Ozempic and similar drugs have dominated the conversation about our bodies and our health. And we hear from listeners around the country who weigh in with their questions and stories.
Tell us what you think. We're @noteswithkai on Instagram and X (Twitter). Email us at [email protected]. Send us a voice message by recording yourself on your phone and emailing us, or record one here.
Notes from America airs live on Sundays at 6 p.m. ET. The podcast episodes are lightly edited from our live broadcasts.
Tell us what you think. We're @noteswithkai on Instagram and X (Twitter). Email us at [email protected]. Send us a voice message by recording yourself on your phone and emailing us, or record one here.
Notes from America airs live on Sundays at 6 p.m. ET. The podcast episodes are lightly edited from our live broadcasts.

43,835 Listeners

38,475 Listeners

6,822 Listeners

9,191 Listeners

3,984 Listeners

1,573 Listeners

8,423 Listeners

478 Listeners

10,855 Listeners

12,696 Listeners

14,476 Listeners

6,407 Listeners

14,620 Listeners

3,511 Listeners

112,236 Listeners

2,801 Listeners

9,048 Listeners

1,405 Listeners

1,196 Listeners

5,573 Listeners

5,771 Listeners

421 Listeners

16,353 Listeners

15,892 Listeners

2,822 Listeners

644 Listeners

1,972 Listeners

1,587 Listeners

1,725 Listeners

209 Listeners

20 Listeners

12 Listeners